Wilson Disease
Pipeline by Development Stage
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (6)
Total enrollment: 295 patients across 6 trials
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
Real World Evidence Study in Subjects With Wilson's Disease
Establishment of Human Cellular Disease Models for Wilson Disease
Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
Related Jobs
Senior Director, Global Distribution Quality
Intern, Environmental Health and Safety
Intern, Maintenance Coordinator
Facilities Technician II (GMP) – Pitman Schedule (12:00 AM–10:00 AM)
Medical Science Liaison
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.